Role of magnetic resonance spectroscopy and diffusion-weighted imaging in characterizing intra axial brain tumours
DOI:
https://doi.org/10.18203/2320-6012.ijrms20233026Keywords:
Diffusion-weighted images, Intra-axial brain tumour, Apparent diffusion coefficient, Magnetic resonance spectroscopyAbstract
Background: Magnetic Resonance imaging (MRI) is essential for assessing intracranial malignancies, but conventional MRI has limitations in tumour grading and infiltration information. Advanced Magnetic Resonance (MR) sequences, such as diffusion-weighted (DW) and Magnetic Resonance spectroscopy (MRS), can differentiate between low-grade and high-grade tumours, aiding treatment decisions. This study aims to evaluate the efficacy of diffusion-weighted imaging and magnetic resonance spectroscopy in grading intra-axial brain tumours and correlating the results with histopathology.
Methods: This retrospective study involved 45 patients over one year at Apollo Hospital. MR imaging included conventional sequences, DW, and MRS with localizers in all three planes. DWI and ADC maps were obtained using specific b-values. Standard mean Apparent Diffusion Coefficient (ADC) values were automatically calculated for intra-lesional and peri-lesional regions.
Results: Intralesional ADC values did not significantly differ between high-grade primary tumours (0.4-1 x 10-3 mm2/s, mean 0.7) and metastases (0.4-0.8 x 10-3 mm2/s, mean 0.7). However, peri-lesional ADC values were lower in primary tumours (0.3-1.3 x 10-3 mm2/s, mean 0.8), indicating peri-lesional infiltration, while higher in metastases (1.2-1.6 x 10-3 mm2/s, mean 1.4) due to the absence of peri-lesional infiltration. Additionally, intralesional ADC values showed a significant difference between low-grade tumours (1-2 x 10-3 mm2/s) and high-grade tumours (0.4-1 x 10-3 mm2/s), allowing for their distinction. There were significantly increased Cho/NAA and Cho/Cr ratios in high-grade tumours compared to low-grade tumours.
Conclusions: MR spectroscopy and DWI with computation of ADC values can enhance the diagnostic effectiveness of MR imaging in detecting and grading malignant brain tumours.
Metrics
References
Svolos P, Kousi E, Kapsalaki E, Theodorou K, Fezoulidis I, Kappas C, et al. The role of diffusion and perfusion weighted imaging in the differential diagnosis of cerebral tumours: a review and future perspectives. Cancer Imag. 2014;14(1):20.
Bulakbasi N, Kocaoglu M, Ors F, Tayfun C, Uçöz T. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumours. AJNR Am J Neuroradiol. 2003;24(2):225-33.
Chiang IC, Kuo YT, Lu CY, Yeung KW, Lin WC, Sheu FO, et al. Distinction between high-grade gliomas and solitary metastases using peritumoural 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings. Neuroradiol. 2004;46(8):619-27.
Smith JK, Castillo M, Kwock L. MR spectroscopy of brain tumours. Mag Resonan Imag Clin North Ame. 2003;11(3):415-29.
Dawoud MAE, Sherif MF, Eltomey MA. Apparent diffusion coefficient and Magnetic resonance spectroscopy in grading of malignant brain neoplasms. Egypt J Radio Nucl Medi. 2014;45(4):1215-22.
Yamasaki F, Kurisu K, Satoh K, Arita K, Sugiyama K, Ohtaki M, et al. Apparent diffusion coefficient of human brain tumours at MR imaging. Radiol. 2005;235(3):985-91.
Naser RKA, Hassan AAK, Shabana AM, Omar NN. Role of magnetic resonance spectroscopy in grading of primary brain tumours. Egypt J Radiol Nucl Medi. 2016;47(2):577-84.
Gupta K, Jain N, Saggar K. Role of diffusion weighted imaging and MR spectroscopy in characterisation of intracranial neoplasms. Int J Anat Radiol Surg. 2018;7(3):RO55-61.
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumours of the central nervous system: a summary. Neuro-Oncol. 2021;23(8):1231-51.
Shokry A. MRS of brain tumours: Diagrammatic representations and diagnostic approach. Egypt J Radio Nucl Medi. 2012;43(4):603-12.
Darwiesh AMN, Maboud NMAE, Khalil AMR, ElSharkawy AM. Role of magnetic resonance spectroscopy and diffusion weighted imaging in differentiation of supratentorial brain tumours. Egypt J Radiol Nucl Medi. 2016;47(3):1037-42.
Sibtain NA, Howe FA, Saunders DE. The clinical value of proton magnetic resonance spectroscopy in adult brain tumours. Clin Radiol. 2007;62(2):109-19.
Martínez-Bisbal MC, Celda B. Proton magnetic resonance spectroscopy imaging in the study of human brain cancer. Q J Nucl Med Mol Imag. 2009;53(6):618-30.
Delorme S, Weber M. Applications of MRS in the evaluation of focal malignant brain lesions. Cancer Imag. 2006;6(1):95-9.
Van Der Graaf M. In vivo magnetic resonance spectroscopy: basic methodology and clinical applications. Eur Biophys J. 2010;39(4):527-40.
Opstad KS, Murphy MM, Wilkins PR, Bell BA, Griffiths JR, Howe FA. Differentiation of metastases from high-grade gliomas using short echo time1H spectroscopy. J Magn Reson Imag. 2004;20(2):187-92.
Chen J, Huang SL, Li T, Chen XL. In vivo research in astrocytoma cell proliferation with 1H-magnetic resonance spectroscopy: correlation with histopathology and immunohistochemistry. Neuroradiol. 2006;48(5):312-8.
Faria AV, Macedo FC, Marsaioli AJ, Ferreira MMC, Cendes F. Classification of brain tumour extracts by high resolution 1H MRS using partial least squares discriminant analysis. Braz J Med Biol Res. 2011;44(2):149-64.
Pavlisa G, Rados M, Pavlisa G, Pavic L, Potocki K, Mayer D. The differences of water diffusion between brain tissue infiltrated by tumour and peritumoural vasogenic edema. Clin Imag. 2009;33(2):96-101.
Lee EJ, TerBrugge K, Mikulis D, Choi DS, Bae JM, Lee SK, et al. Diagnostic value of peritumoural minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions. AJR Am J Roentgenol. 2011;196(1):71-6.
Ohba S, Nakagawa T, Murakami H, Ushioda T, Shimizu K. Diffusion magnetic resonance imaging for enhanced visualization of malignant cerebral tumours and abscesses. Neurol India. 2011;59(5):674.
Downloads
Published
How to Cite
Issue
Section
